CUMC runners will be among the 50,000 competing in the TCS NYC Marathon on Sunday. Read their stories, then cheer them on as they race through your borough.
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
